| Preoperative versus postoperative chemoradiotherapy for rectal cancer R Sauer, H Becker, W Hohenberger, C Rödel, C Wittekind, R Fietkau, ... New England Journal of Medicine 351 (17), 1731-1740, 2004 | 7549 | 2004 |
| Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up R Glynne-Jones, L Wyrwicz, E Tiret, G Brown, C Rödel, A Cervantes, ... Annals of Oncology 28, iv22-iv40, 2017 | 2438* | 2017 |
| Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up … R Sauer, T Liersch, S Merkel, R Fietkau, W Hohenberger, C Hess, ... Journal of Clinical Oncology 30 (16), 1926-1933, 2012 | 2398 | 2012 |
| Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data M Maas, PJ Nelemans, V Valentini, P Das, C Rödel, LJ Kuo, FA Calvo, ... The lancet oncology 11 (9), 835-844, 2010 | 2139 | 2010 |
| Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer C Rödel, P Martus, T Papadoupolos, L Füzesi, M Klimpfinger, ... Journal of clinical oncology 23 (34), 8688-8696, 2005 | 1494 | 2005 |
| S3-Leitlinie „Kolorektales Karzinom “–Aktualisierung 2008. Ergebnis einer evidenzbasierten Konsensuskonferenz (8.–9. Juni 2007) W Schmiegel, A Reinacher-Schick, D Arnold, U Graeven, V Heinemann, ... Z gastroenterol 46 (8), 799-840, 2008 | 945* | 2008 |
| Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of … C Rödel, T Liersch, H Becker, R Fietkau, W Hohenberger, T Hothorn, ... The lancet oncology 13 (7), 679-687, 2012 | 890 | 2012 |
| Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results C Rödel, GG Grabenbauer, R Kühn, T Papadopoulos, J Dunst, ... Journal of clinical oncology 20 (14), 3061-3071, 2002 | 845 | 2002 |
| Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. TG Wendt, GG Grabenbauer, CM Rödel, HJ Thiel, H Aydin, R Rohloff, ... Journal of Clinical Oncology 16 (4), 1318-1324, 1998 | 834 | 1998 |
| Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized … V Valentini, RGPM Van Stiphout, G Lammering, MA Gambacorta, ... Journal of clinical oncology 29 (23), 3163-3172, 2011 | 577 | 2011 |
| EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum CJH van de Velde, PG Boelens, JM Borras, JW Coebergh, A Cervantes, ... European journal of cancer 50 (1), 1. e1-1. e34, 2014 | 569 | 2014 |
| Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final … C Rödel, U Graeven, R Fietkau, W Hohenberger, T Hothorn, D Arnold, ... The Lancet Oncology 16 (8), 979-989, 2015 | 563 | 2015 |
| Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial E Fokas, T Liersch, R Fietkau, W Hohenberger, T Beissbarth, C Hess, ... Journal of Clinical Oncology 32 (15), 1554-1562, 2014 | 503 | 2014 |
| Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 E Fokas, M Allgäuer, B Polat, G Klautke, GG Grabenbauer, R Fietkau, ... Journal of Clinical Oncology 37 (34), 3212-3222, 2019 | 477 | 2019 |
| Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review G Ploussard, S Daneshmand, JA Efstathiou, HW Herr, ND James, ... European urology 66 (1), 120-137, 2014 | 414 | 2014 |
| Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer D Zips, K Zöphel, N Abolmaali, R Perrin, A Abramyuk, R Haase, S Appold, ... Radiotherapy and Oncology 105 (1), 21-28, 2012 | 401* | 2012 |
| Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer F Rödel, J Hoffmann, L Distel, M Herrmann, T Noisternig, ... Cancer research 65 (11), 4881-4887, 2005 | 383 | 2005 |
| Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer C Rödel, GG Grabenbauer, T Papadopoulos, W Hohenberger, ... Journal of clinical oncology 21 (16), 3098-3104, 2003 | 368 | 2003 |
| Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery M Den Dulk, CAM Marijnen, L Collette, H Putter, L Påhlman, J Folkesson, ... Journal of British Surgery 96 (9), 1066-1075, 2009 | 360 | 2009 |
| Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer P Balermpas, Y Michel, J Wagenblast, O Seitz, C Weiß, F Rödel, C Rödel, ... British journal of cancer 110 (2), 501-509, 2014 | 355 | 2014 |